Maze Therapeutics Inc. (MAZE)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$42.88
Day's range
$45.65

Maze Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 08/14/2026 5.03 M $150.18 M   10.20% 8.53%
TRV GP IV, LLC 08/10/2026 4.47 M $133.50 M   0.00% 7.58%
ARCH VENTURE MANAGEMENT, LLC 08/14/2026 4.12 M $122.98 M   0.00% 6.98%
DEEP TRACK CAPITAL, LP 08/14/2026 3.73 M $111.38 M   7.33% 6.33%
BLACKROCK, INC. 08/07/2026 3.50 M $104.52 M   36.27% 5.94%
JUPITER TOPCO LLC 08/14/2026 3.41 M $101.76 M   100.00% 5.78%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 2.60 M $77.69 M   100.00% 4.41%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 1.94 M $57.74 M   56.68% 3.28%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.78 M $53.06 M   23.86% 3.01%
AH CAPITAL MANAGEMENT, L.L.C. 08/14/2026 1.70 M $50.79 M   0.00% 2.89%
VR ADVISER, LLC 08/14/2026 1.60 M $47.80 M   0.00% 2.72%
ALPHABET INC. 08/07/2026 1.39 M $41.44 M   0.00% 2.35%
BRAIDWELL LP 08/14/2026 1.14 M $34.02 M   100.00% 1.93%
FARALLON CAPITAL MANAGEMENT LLC 08/14/2026 1.11 M $33.06 M   197.00% 1.88%
FMR LLC 08/13/2026 1.06 M $31.54 M   22.30% 1.79%
GENERAL CATALYST GROUP MANAGEMENT, LLC 08/17/2026 1.04 M $30.91 M   0.00% 1.76%
STATE STREET CORP 09/22/2026 997.53 K $29.77 M   56.67% 1.69%
JPMORGAN CHASE & CO 08/12/2026 964.01 K $28.00 M   1,549.40% 1.63%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 954.89 K $28.49 M   50.10% 1.62%
TRV GP V, LLC 08/10/2026 950.80 K $28.37 M   0.00% 1.61%
MARSHALL WACE, LLP 08/13/2026 914.57 K $27.29 M   194.42% 1.55%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 858.05 K $25.61 M   43.02% 1.45%
CITADEL ADVISORS LLC 09/02/2026 852.68 K $25.44 M   9.92% 1.45%
CASDIN CAPITAL, LLC 08/14/2026 843.86 K $25.18 M   11.20% 1.43%
ARROWMARK COLORADO HOLDINGS LLC 08/13/2026 767.38 K $22.90 M   0.00% 1.30%
WOODLINE PARTNERS LP 08/14/2026 736.22 K $21.97 M   13.22% 1.25%
BESSEMER GROUP INC 08/12/2026 481.79 K $14.38 M   0.00% 0.82%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2026 417.56 K $12.46 M   83.67% 0.71%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 393.11 K $11.73 M   101.03% 0.67%
ABRDN PLC 07/31/2026 383.77 K $11.45 M   69.64% 0.65%
IKARIAN CAPITAL, LLC 08/14/2026 379.00 K $11.31 M   0.00% 0.64%
HHLR ADVISORS, LTD. 08/14/2026 366.03 K $10.92 M   0.00% 0.62%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 339.28 K $10.12 M   577.27% 0.58%
SQUADRON CAPITAL MANAGEMENT LLC 08/14/2026 335.00 K $10.00 M   30.10% 0.57%
BANK OF AMERICA CORP /DE/ 08/14/2026 321.23 K $9.59 M   64.66% 0.54%
NORTHERN TRUST CORP 08/13/2026 294.74 K $8.80 M   39.44% 0.50%
GOLDMAN SACHS GROUP INC 08/14/2026 293.14 K $8.75 M   4.80% 0.50%
CANDRIAM S.C.A. 08/13/2026 273.93 K $8.17 M   -1.52% 0.46%
HUDSON BAY CAPITAL MANAGEMENT LP 08/14/2026 270.00 K $8.06 M   3,212.88% 0.46%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 260.57 K $7.78 M   39.76% 0.44%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 260.57 K $7.78 M   100.00% 0.44%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 248.00 K $7.40 M   -78.95% 0.42%
MASS GENERAL BRIGHAM, INC 08/07/2026 239.99 K $7.16 M   0.00% 0.41%
AMERIPRISE FINANCIAL INC 08/14/2026 227.43 K $6.79 M   111.59% 0.39%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 219.94 K $6.56 M   45.65% 0.37%
RTW INVESTMENTS, LP 08/14/2026 212.00 K $6.33 M   100.00% 0.36%
SCHRODER INVESTMENT MANAGEMENT GROUP 08/13/2026 199.87 K $5.80 M   437.56% 0.34%
TWO SIGMA INVESTMENTS, LP 08/14/2026 192.95 K $5.76 M   1,117.75% 0.33%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 188.86 K $5.64 M   -33.61% 0.32%
EXODUSPOINT CAPITAL MANAGEMENT, LP 08/14/2026 183.26 K $5.47 M   100.00% 0.31%

Maze Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 210 institutional investors and hedge funds held shares of Maze Therapeutics Inc.. The most heavily invested institutionals were:

Frazier Life Sciences Management, L.P.: 5.03 M

TRV GP IV, LLC: 4.47 M

ARCH Venture Management, LLC: 4.12 M

Deep Track Capital, LP: 3.73 M

BlackRock, Inc.: 3.5 M

Jupiter Topco LLC: 3.41 M

99.66% of Maze Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 63.40 M shares in the last 24 months. This purchase volume represents approximately $2.86 B in transactions.